Nanogen Shares Down 6.7 Percent on Lackluster Q4 Revenues, Widened Losses

Feb 24, 2005

NEW YORK, Feb. 24 (GenomeWeb News) - Shares in Nanogen were down 6.67 percent, or $.29, at $4.07 in late-afternoon trading after the company yesterday reported a 51-percent fall-off in fourth-quarter revenue and an 89-percent increase in its net losses.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Breaking News

The Scan

What You Might Learn

The UK's Human Fertility and Embryology Authority calls for consumer genetic testing companies to warn customers that testing could uncover family secrets, according to the Guardian.

From Whales to Urchins to Algae

The New York Times reports that United Nations delegates have been discussing how to govern the genetic resources of the deep sea.

In the Skin

Researchers have transplanted edited cells into mice that appear to combat cocaine addiction, New Scientist reports.

This Week in PNAS

In PNAS this week: analysis of proteolytic enzymes secreted by circulating tumor cells, phylogenetic study of Fv1 evolution, and more.

Main menu